BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18418463)

  • 1. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
    Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
    Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer.
    Wettergren Y; Odin E; Carlsson G; Gustavsson B
    Mol Med; 2010; 16(9-10):425-32. PubMed ID: 20549016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
    Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
    Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
    Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
    Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of the p16 gene and loss of its protein expression is correlated with tumor progression in extrahepatic bile duct carcinomas.
    Hong SM; Choi J; Ryu K; Ro JY; Yu E
    Arch Pathol Lab Med; 2006 Jan; 130(1):33-8. PubMed ID: 16390235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of p16 promoter hypermethylation in colorectal cancer: a meta-analysis.
    Jiang W; Wang PG; Zhan Y; Zhang D
    Cancer Invest; 2014 Feb; 32(2):43-52. PubMed ID: 24410593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients.
    Odin E; Wettergren Y; Nilsson S; Willén R; Carlsson G; Spears CP; Larsson L; Gustavsson B
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6012-9. PubMed ID: 14676127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
    Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
    BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
    Bradly DP; Gattuso P; Pool M; Basu S; Liptay M; Bonomi P; Buckingham L
    Diagn Mol Pathol; 2012 Dec; 21(4):207-13. PubMed ID: 23111194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation profile of promoter region of p16 gene in colorectal cancer patients of Kashmir valley.
    Wani HA; Beigh MA; Amin S; Bhat AA; Bhat S; Khan H; Mattoo AA; Showkat M; Masood A; Majid S
    J Biol Regul Homeost Agents; 2013; 27(2):297-307. PubMed ID: 23830381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of DNA Hypermethylation and Hypomethylation induced by Folate Deficiency in Sporadic Colorectal Cancer and Clinical Implication Analysis of Hypermethylation Pattern in CBS Promoter.
    Zhang Z; He Y; Tu X; Huang S; Chen Z; Wang L; Song J
    Clin Lab; 2017 Apr; 63(4):733-748. PubMed ID: 28397458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
    Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
    J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
    Shima K; Nosho K; Baba Y; Cantor M; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
    Int J Cancer; 2011 Mar; 128(5):1080-94. PubMed ID: 20473920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
    Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
    PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation.
    Wierzbicki PM; Adrych K; Kartanowicz D; Stanislawowski M; Kowalczyk A; Godlewski J; Skwierz-Bogdanska I; Celinski K; Gach T; Kulig J; Korybalski B; Kmiec Z
    World J Gastroenterol; 2013 Jul; 19(27):4363-73. PubMed ID: 23885148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p16INK4a, alone or combined with p53, is predictive of better prognosis in colorectal adenocarcinoma in Tunisian patients.
    Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Amouri A; Frikha F; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):562-8. PubMed ID: 22095233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer.
    Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Roh JK; Ahn JB
    Cancer Res Treat; 2016 Jan; 48(1):208-15. PubMed ID: 25943321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
    Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
    Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.